SI-BONE (NASDAQ:SIBN) Releases Earnings Results, Beats Estimates By $0.09 EPS

SI-BONE (NASDAQ:SIBN - Get Free Report) released its earnings results on Monday. The company reported ($0.15) earnings per share for the quarter, beating the consensus estimate of ($0.24) by $0.09, Zacks reports. The business had revenue of $47.29 million during the quarter, compared to analysts' expectations of $45.13 million. SI-BONE had a negative net margin of 23.82% and a negative return on equity of 22.51%. SI-BONE updated its FY 2025 guidance to EPS.

SI-BONE Stock Up 7.7 %

Shares of NASDAQ SIBN traded up $1.34 during mid-day trading on Thursday, hitting $18.81. The company had a trading volume of 502,640 shares, compared to its average volume of 367,456. The company has a current ratio of 8.25, a quick ratio of 7.22 and a debt-to-equity ratio of 0.22. The firm has a 50-day simple moving average of $14.49 and a two-hundred day simple moving average of $14.73. The company has a market capitalization of $799.97 million, a PE ratio of -20.45 and a beta of 0.82. SI-BONE has a one year low of $11.70 and a one year high of $19.16.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on the stock. Needham & Company LLC restated a "buy" rating and issued a $24.00 price target on shares of SI-BONE in a research report on Tuesday. Cantor Fitzgerald reissued an "overweight" rating and issued a $25.00 price objective on shares of SI-BONE in a research note on Tuesday. Finally, Truist Financial lifted their price target on SI-BONE from $20.00 to $22.00 and gave the company a "buy" rating in a report on Tuesday.

Insider Buying and Selling at SI-BONE

In related news, insider Anthony J. Recupero sold 3,311 shares of SI-BONE stock in a transaction that occurred on Wednesday, April 2nd. The stock was sold at an average price of $14.15, for a total transaction of $46,850.65. Following the completion of the sale, the insider now directly owns 284,555 shares of the company's stock, valued at approximately $4,026,453.25. This trade represents a 1.15 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, SVP Michael A. Pisetsky sold 3,128 shares of the firm's stock in a transaction on Wednesday, April 2nd. The stock was sold at an average price of $14.14, for a total value of $44,229.92. Following the transaction, the senior vice president now owns 244,878 shares in the company, valued at approximately $3,462,574.92. This trade represents a 1.26 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 6,775 shares of company stock worth $95,711 over the last ninety days. 3.90% of the stock is currently owned by corporate insiders.

SI-BONE Company Profile

SI-BONE, Inc, a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products.